Viimased uudised ja artiklid geneetiliste testide kohta
January 3, 2026
Researchers have identified a parasite that can suppress pain perception in its host, allowing it to infect the body undetected. The parasite's ability to evade the immune system is made possible by its unique mechanism of silencing pain signals.
January 3, 2026
A recent study has revealed that social media beauty trends on TikTok are having a negative impact on young girls' skin health. The trend is leading to an increase in skin-related problems, including burns and scarring.
January 2, 2026
A recent study has identified 15 Pennsylvania counties with significantly increasing rates of melanoma, a type of skin cancer. The findings suggest that these areas may require targeted interventions to address the growing health concern.
January 2, 2026
Researchers have identified a parasite that exploits a unique mechanism to evade detection by the host's immune system and disrupt pain signaling pathways, allowing it to establish infection. This phenomenon highlights an intriguing example of parasitic evolution and its implications for human disease.
January 2, 2026
University of Pennsylvania School of Medicine. "Scientists say this viral rosemary skincare trend actually works." ScienceDaily. ScienceDaily, 7 December 2025. <www.sciencedaily.com/releases/2025/1...
January 2, 2026
A recent study has discovered the presence of micro-nano-plastics in artery-clogging plaque found in the neck arteries of individuals. This finding suggests a potential link between exposure to plastic particles and cardiovascular disease.
January 1, 2026
A study has found that individuals develop unique patterns of finger wrinkling when exposed to water for an extended period. These patterns are consistent and remain unchanged, even after multiple exposure events.
January 1, 2026
Researchers at Lund University have discovered a specific combination of genetic mutations that significantly increases an individual's risk of blood clots. This mutation combo is associated with an 180% higher clot risk compared to the general population.
January 1, 2026
Researchers at the University of Massachusetts Amherst have developed an experimental vaccine that demonstrates promising results in suppressing cancer growth in laboratory settings. The vaccine, still in its early stages, shows potential for further investigation as a treatment option.
